Search Results (801)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer. | Academic Article |
Why?
|
| ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium. | Academic Article |
Why?
|
| Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium. | Academic Article |
Why?
|
| Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium. | Academic Article |
Why?
|
| Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer. | Academic Article |
Why?
|
| Optimal treatment of multiple ipsilateral primary breast cancers. | Academic Article |
Why?
|
| Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. | Academic Article |
Why?
|
| Bacterial Infections and Cancer: Exploring This Association And Its Implications for Cancer Patients. | Academic Article |
Why?
|
| Prognostic features of endometrial cancer metastasis to the central nervous system. | Academic Article |
Why?
|
| No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. | Academic Article |
Why?
|
| ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. | Academic Article |
Why?
|
| Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. | Academic Article |
Why?
|
| Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's Cancers. | Academic Article |
Why?
|
| A Curated Cancer Clinical Outcomes Database (C3OD) for accelerating patient recruitment in cancer clinical trials. | Academic Article |
Why?
|
| Patterns and predictors of genetic referral among ovarian cancer patients at a National Cancer Institute-Comprehensive Cancer Center. | Academic Article |
Why?
|